Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 347

1.

The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.

Ikeda K, Ogawa Y, Kajino C, Deguchi S, Kurihara S, Tashima T, Goto W, Nishiguchi Y, Tokunaga S, Fukushima H, Inoue T.

Eur J Surg Oncol. 2014 Jul;40(7):818-23. doi: 10.1016/j.ejso.2014.03.023. Epub 2014 Apr 15.

PMID:
24768416
2.

Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.

Helyer LK, Varnic M, Le LW, Leong W, McCready D.

Breast J. 2010 Jan-Feb;16(1):48-54. doi: 10.1111/j.1524-4741.2009.00855.x. Epub 2009 Nov 2.

PMID:
19889169
3.

Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?

Tausch C, Baege A, Dietrich D, Vergin I, Heuer H, Heusler RH, Rageth C.

Eur J Surg Oncol. 2013 Aug;39(8):880-6. doi: 10.1016/j.ejso.2013.05.009. Epub 2013 Jun 2.

PMID:
23735162
4.

Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.

Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS, Klimberg VS.

J Am Coll Surg. 2008 May;206(5):1038-42; discussion 1042-4. doi: 10.1016/j.jamcollsurg.2007.12.022. Epub 2008 Mar 3.

PMID:
18471751
5.

Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients.

Ikeda K, Ogawa Y, Komatsu H, Mori Y, Ishikawa A, Nakajima T, Oohira G, Tokunaga S, Fukushima H, Inoue T.

World J Surg Oncol. 2012 Nov 1;10:233. doi: 10.1186/1477-7819-10-233.

6.

The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.

Klompenhouwer EG, Gobardhan PD, Beek MA, Voogd AC, Luiten EJ.

Trials. 2013 Apr 25;14:111. doi: 10.1186/1745-6215-14-111.

7.

Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer.

Connor C, McGinness M, Mammen J, Ranallo L, Lafaver S, Klemp J, Fan F, Mahnken J.

Ann Surg Oncol. 2013 Oct;20(10):3303-7. doi: 10.1245/s10434-013-3113-4. Epub 2013 Aug 22.

PMID:
23975287
8.

The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.

Rebegea L, Firescu D, Dumitru M, Anghel R.

Chirurgia (Bucur). 2015 Jan-Feb;110(1):33-7.

9.

Axillary reverse mapping to prevent lymphedema after breast cancer surgery: defining the limits of the concept.

Khan SA.

J Clin Oncol. 2009 Nov 20;27(33):5494-6. doi: 10.1200/JCO.2009.24.3311. Epub 2009 Oct 13. No abstract available.

10.
11.

Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.

Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK.

Lymphology. 2004 Jun;37(2):73-91.

PMID:
15328760
12.

Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.

Seyednejad N, Kuusk U, Wiseman SM.

Expert Rev Anticancer Ther. 2014 Jul;14(7):771-81. doi: 10.1586/14737140.2014.896209. Epub 2014 Mar 13. Review.

PMID:
24621187
13.

Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?

Khandelwal R, Poovamma CU, Shilpy C, Prema M, Anthony P.

Breast Dis. 2014 Jan 1;34(4):151-5. doi: 10.3233/BD-140371.

PMID:
24934169
14.

Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.

Ponzone R, Cont NT, Maggiorotto F, Cassina E, Mininanni P, Biglia N, Sismondi P.

J Clin Oncol. 2009 Nov 20;27(33):5547-51. doi: 10.1200/JCO.2009.22.1846. Epub 2009 Oct 13.

15.

[Axillary reverse mapping. preserving nodes during an axillary lymph node dissection].

Gobardhan PD, Klompenhouwer EG, Beek MA, Voogd AC, Luiten EJ.

Ned Tijdschr Geneeskd. 2013;157(22):A5646. Dutch.

PMID:
23714290
16.

Axillary reverse mapping in breast cancer: a Canadian experience.

Kuusk U, Seyednejad N, McKevitt EC, Dingee CK, Wiseman SM.

J Surg Oncol. 2014 Dec;110(7):791-5. doi: 10.1002/jso.23720. Epub 2014 Jul 23.

PMID:
25053441
17.

Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery.

Miller CL, Specht MC, Skolny MN, Jammallo LS, Horick N, O'Toole J, Coopey SB, Hughes K, Gadd M, Smith BL, Taghian AG.

Breast Cancer Res Treat. 2012 Oct;135(3):781-9. doi: 10.1007/s10549-012-2231-1. Epub 2012 Sep 1.

18.
19.

Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients.

Soares EW, Nagai HM, Bredt LC, da Cunha AD Jr, Andrade RJ, Soares GV.

World J Surg Oncol. 2014 Mar 27;12:67. doi: 10.1186/1477-7819-12-67.

20.

Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.

McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ.

J Clin Oncol. 2008 Nov 10;26(32):5213-9. doi: 10.1200/JCO.2008.16.3725. Epub 2008 Oct 6. Erratum in: J Clin Oncol. 2010 Apr 1;28(10):1808.

Items per page

Supplemental Content

Write to the Help Desk